Safety Study of Intravenous Immunoglobulin (IVIG) Post-Portoenterostomy in Infants With Biliary Atresia
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Averell Sherker, MD
National Institute of Diabetes and Digestive and Kidney Disease (NIDDK)
Study Director - Ed Doo, MD
National Institute of Diabetes and Digestive and Kidney Disease (NIDDK)
Study Director - Ronald Sokol, MD
Children's Hospital Colorado
Study Chair
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
7 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Hospital for Sick Children
Toronto, Ontario, Canada
- Children'S Hospital Los Angeles
Los Angeles, California, United States
- Children'S Hospital Colorado
Aurora, Colorado, United States
- Children'S Healthcare of Atlanta
Atlanta, Georgia, United States
- Children'S Hospital Medical Center
Cincinnati, Ohio, United States
- Children'S Hospital of Philadelphia
Philadelphia, Pennsylvania, United States
- Children'S Hospital at Pittsburgh
Pittsburgh, Pennsylvania, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 31 Oct 2013
- Primary completion
- 31 Jul 2016
- Completion
- 31 Jul 2016
- Last update posted
- 1 Oct 2019
- Registered enrollment
- 30
- Registry id
- NCT01854827
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.